From “Pipeline Licensing” to “Global Co-Creation”: The 2025 Paradigm Shift in China’s Biopharmaceutical NewCo Transactions
GAO Hao-tian, DING Hong-xia
China Food Drug Administration . 2026, (4): 153 -155 .  DOI: 10.3969/j.issn.1673-5390.2026.04.018